Search - tctmd.com

Displaying 101 - 120 of 952

Sort: Relevancy | Date

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Todd Neale

February 25, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Industry News

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

February 18, 2016

Presentation JIM 2016

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Presenter: Alberto Menozzi

February 11, 2016

Presentation JIM 2016

Optimal Duration of Oral Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

February 11, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Todd Neale

February 07, 2016

News Daily News

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

Yael L. Maxwell

January 25, 2016

News Daily News

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Yael L. Maxwell

January 25, 2016

News Daily News

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Yael L. Maxwell

January 25, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

TRAPID-AMI Published: Early Diagnosis of Acute MI Ruled Out Within 1 Hour Using High-Sensitivity Troponin

L.A. McKeown

January 20, 2016

News Daily News

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Shelley Wood

January 18, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

Advertisement

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Optimal Duration of Oral Antiplatelet Therapy

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

TRAPID-AMI Published: Early Diagnosis of Acute MI Ruled Out Within 1 Hour Using High-Sensitivity Troponin

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content